Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration
- DOI
- 10.1111/bph.70387
- Published
- 2026-03-05
- Container
- British Journal of Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bph.70387,
title = {Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration},
author = {Radka Kočvarová and Shahar Azar and Bella Agranovich and Ifat Abramovich and Saveliy Kirillov and Alina Nemirovski and Saja Baraghithy and Inbar Plaschkes and Emmanuelle Merquiol and Alexander Rouvinski and Galia Blum and Liad Hinden and Joseph Tam},
year = {2026},
journal = {British Journal of Pharmacology},
doi = {10.1111/bph.70387},
url = {https://doi.org/10.1111/bph.70387}
}RIS
TY - JOUR TI - Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration AU - Radka Kočvarová AU - Shahar Azar AU - Bella Agranovich AU - Ifat Abramovich AU - Saveliy Kirillov AU - Alina Nemirovski AU - Saja Baraghithy AU - Inbar Plaschkes AU - Emmanuelle Merquiol AU - Alexander Rouvinski AU - Galia Blum AU - Liad Hinden AU - Joseph Tam PY - 2026 JO - British Journal of Pharmacology DO - 10.1111/bph.70387 UR - https://doi.org/10.1111/bph.70387 ER -
APA
Kočvarová, R., Azar, S., Agranovich, B., Abramovich, I., Kirillov, S., Nemirovski, A., Baraghithy, S., Plaschkes, I., Merquiol, E., Rouvinski, A., Blum, G., Hinden, L., & Tam, J. (2026). Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration. British Journal of Pharmacology. https://doi.org/10.1111/bph.70387
Source records
- crossref · retrieved 2026-09-25T03:59:45.038Z